This compound is a retinoid-related impurity associated with the pharmaceutical intermediate acitretin. It is characterized as a polyenoic acid derivative with a methoxy-substituted trimethylphenyl group, reflecting its structural relationship to the active pharmaceutical ingredient.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Carbamic acid, N-[2,2-dimethyl-5-[2-(4-octylphenyl)ethenyl]-1,3-dioxan-5-yl]-, phenylmethyl ester
pharmaceutical intermediate
N(alpha)-t-butoxycarbonyl-L-leucine
pharmaceutical intermediate
Boc-L-Isoleucine
pharmaceutical intermediate
Zinc peroxide
pharmaceutical intermediate
(2E,4E,6E,8E)-3-ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-7-methylnona-2,4,6,8-tetraenoic acid
HDQYWMRVKXRMSY-RYNQQPDDSA-N
CC/C(=C\C(=O)O)/C=C/C=C(\C)/C=C/C1=C(C(=C(C=C1C)OC)C)C
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.